Abstract:Background: HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is a unique disease with improved prognosis which could benefit from treatment de-escalation. Current radiographic-based biomarkers mainly focus on primary tumor (PT) alone, neglecting the potential prognostic value from the lymph node (LN). In this work, we constructed a radiomic model integrating texture features from both PT and LN to predict overall survival (OS) in HPV-associated OPSCC patients. Methods: Pretreatment CT scans for 647 OPSCC patients treated with definitive radiation with or without chemotherapy were acquired from The Cancer Imaging Archive (TCIA) and the Cleveland Clinic (CCF), which were divided into training set D1 (n=294) and test set D2 (n=353). PT and LN contours were annotated by three. 2045 texture radiomic features were extracted from both PT and LN and were concatenated as input to a LASSO Cox model to predict OS. We used the harrell's concordance index (C-index) and hazard ratio (HR) to evaluate the prognostic performance. We also performed the multivariable cox proportional hazard analysis adjusting for clinicopathological variables to validate the independent prognostic significance. Results: Among the 647 patients, median follow-up time was 70.23 months, with 155 patients (24%) experienced death. 22.6%, 38.8%, 23.2% and 15.4% had T stage I, II, III and IV tumors, respectively. 203 patients (31.4%) were treated with radiation alone. The model integrating PT and LN (M_PTLN) yielded higher C-index compared to PT alone (M_PT) on D1 (0.74 vs 0.66) and on D2 (0.64 vs 0.61). In univariate analysis on D2, M_PTLN is prognostic of OS (HR, 2.26; 95% CI, 1.32 - 3.87; log rank p = 0.003). In multivariable analysis, M_PTLN is still statistically significant (p = 0.04) accounting for clinicopathologic factors (age, gender, smoking pack-year [PY], T stage, N stage and treatment modality). Conclusions: We developed and validated a CT-based survival prediction model for HPV-associated OPSCC patients with significant prognostic values, accounting for both primary tumor and lymph node. If prospectively validated, the model has the potential to inform trial eligibility and treatment-related decision making. Citation Format: Bolin Song, Amaury Leroy, Kailin Yang, Qiyun Liu, Xiao Li, Jonathan Lee, Sarah Stock, Nabil F. Saba, James S. Lewis, Eric Deutsch, Mehmet Asim Bilen, Shlomo A. Koyfman, Anant Madabhushi. Integrating radiomic features from primary tumor and lymph node for survival prediction of HPV-associated oropharyngeal squamous cell carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7661.

Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer

CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma

Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group

Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy

Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review

Differential molecular characterization of human papillomavirus‐associated oropharyngeal squamous cell carcinoma and its prognostic value

Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients with HPV-Associated Oropharyngeal Cancer.

Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma

Identification of Potential Prognostic Biomarkers in Vulval Squamous Cell Carcinoma Based on Human Papillomavirus Infection Status-Analysis of GSE183454

ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study

Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Risk-Stratification in P16+ Oropharyngeal Cancer

Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma

Abstract 7661: Integrating radiomic features from primary tumor and lymph node for survival prediction of HPV-associated oropharyngeal squamous cell carcinoma

Identification of Prognostic Molecular Biomarkers in 157 HPV‐positive and HPV‐negative Squamous Cell Carcinomas of the Oropharynx

Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors

Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration

Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis